BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Resverlogix Corporation 

279 Midpark Way SE
Suite 202
Calgary  Alberta  T2X 1M2  Canada
Phone: 403-254-9252 Fax: 403-256-8495


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Resverlogix Corporation (RVX.TO) Names Michael Sweeney, M.D., As Senior Vice President Of Clinical Development 11/4/2014 8:20:05 AM
Resverlogix Corporation (RVX.TO) Announces Annual General Meeting Voting Results 10/9/2014 9:23:51 AM
Resverlogix Corporation (RVX.TO) Corporate Update Conference Call & Webcast Announcement 10/2/2014 7:54:11 AM
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events 9/2/2014 6:51:51 AM
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014 8:09:14 AM
Resverlogix Corporation (RVX.TO) Shareholders Approve Additional $30 Million From Citibank Loan 8/14/2014 8:31:24 AM
Resverlogix Corporation (RVX.TO) Release: RVX-208 Reduces Major Adverse Cardiovascular Events (MACE) Significantly In Patients With Diabetes Mellitus 7/23/2014 12:33:23 PM
Resverlogix Corporation (RVX.TO) Secures An Additional $30 Million From Citibank Loan 7/7/2014 8:43:28 AM
Resverlogix Corporation (RVX.TO) Release: Leading Life Science Publication SciBX Highlights RVX-208 5/21/2014 10:08:53 AM
Resverlogix Corporation (RVX.TO) Conference Call & Webcast Announcement 2/7/2014 6:22:43 AM
12345678910...